钇-90微球选择性内放射治疗在原发性肝癌中的临床应用及进展
Clinical application and progress of yttrium 90 microsphere selective internal radiation therapy in primary hepatic cancer
张辉 1付颖 2谭斌彬 1邵明华 1刘平 2范超 2陈海蕾 1陈志宇1
作者信息
- 1. 陆军军医大学第一附属医院肝胆外科,重庆 400038
- 2. 陆军军医大学第一附属医院江北院区肝胆外科,重庆 400020
- 折叠
摘要
原发性肝癌是公共卫生领域亟待解决的重大问题之一,严重危害我国人民生命健康.其治疗模式是多学科参与、多种治疗方法协同,即使我国肝癌临床常用的治疗方法众多,治疗结局仍不如人意.钇-90应用20余年,积累了大量国外临床数据.笔者基于临床实践,深入阐述钇-90微球选择性内放射治疗在原发性肝癌中的临床应用及研究进展.
Abstract
Primary hepatic cancer is one of the major problems that need to be solved urgently in the field of public health,seriously endangering the life and health of Chinese people.Its treatment mode is multidisciplinary participation and synergy of multiple therapeutic methods.Even though there are many common clinical treatments for liver cancer in China,its therapeutic outcome is still unsatisfactory.yttrium-90 has been applied for more than 20 years,and a large amount of foreign clinical data have been accumulated.Combining the latest literature and clinical practice,the authors describe the clinical application and research progress of yttrium-90 micro-sphere selective internal radiation therapy in primary liver cancer.
关键词
肝肿瘤/钇-90/选择性内放射治疗/研究进展Key words
Liver neoplasms/Yttrium-90/Selective internal radiotherapy/Research progress引用本文复制引用
基金项目
重庆市自然科学基金(2023NSCQ-MSX3527)
重庆市科卫联合医学科研项目(2024MS XM175)
出版年
2024
NETL
NSTL
万方数据